Katherine C. Fuh

Also affiliated with University of California, San Francisco, San Francisco Foundation, Cancer Research Center, University of San Francisco

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

3.4Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3

Top 8%

2.7DataRank

Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

Papers

Driven by 24 papers — median percentile 81. Top paper: “Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment”.

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3

Top 8%

2.7DataRank

Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery

NAR Cancer(2022)10.1093/narcan/zcac014

Top 31%

0.652DataRank

Top 31%22 citations

Michael W. Lloyd, Jeffrey W. Grover, Nan Xiao, Sara Seepo, Sai Lakshmi Subramanian +95 more

Impact of employment and insurance status on distress in gynecologic oncology patients

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.01.038

N/A

0DataRank · unranked

10 citations

David H. Morris, Molly M. Greenwade, Megan Landon, Andrea R. Hagemann, Premal H. Thaker +8 more

Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer

Cancers(2021)10.3390/cancers13235877

N/A

0DataRank · unranked

7 citations

Elena Lomonosova, Shaina F. Bruce, Joan Tankou, Mary M. Mullen, Angela M. Schab +12 more

Radiation therapy for vaginal and perirectal lesions in recurrent ovarian cancer

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100808

N/A

0DataRank · unranked

3 citations

Jennifer Stanley, Michael Toboni, Julie K. Schwarz, F. Zhang, Andrea R. Hagemann +8 more

DDR2 Expression in Cancer-Associated Fibroblasts Promotes Ovarian Cancer Tumor Invasion and Metastasis through Periostin-ITGB1

Cancers(2022)10.3390/cancers14143482

N/A

0DataRank · unranked

30 citations

Ritu M. Dave, Emily Alpert, Gregory D. Longmore, Katherine C. Fuh, Favour A. Akinjiyan

GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0704

N/A

0DataRank · unranked

16 citations

Kevin Cho, Hollie Noia, Elena Lomonosova, Elizabeth Stock, Alyssa Oplt +13 more

High visceral fat to subcutaneous fat ratios portend a poor prognosis in patients with advanced endometrial cancer

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.09.011

N/A

0DataRank · unranked

12 citations

Mary M. Mullen, Rehan Nizamuddin, Jonathan H. Stein, Lindsay M. Kuroki, Katherine C. Fuh +8 more

State of the Biomarker Science in Ovarian Cancer: A National Cancer Institute Clinical Trials Planning Meeting Report

JCO Precision Oncology(2022)10.1200/po.22.00355

N/A

0DataRank · unranked

8 citations

Katherine C. Fuh, Rebecca C. Arend, Gottfried E. Konecny, Panagiotis A. Konstantinopoulos, Kunle Odunsi +4 more

Gynecologic oncology patient perspectives and knowledge on advance care planning: A quality improvement intervention

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101060

N/A

0DataRank · unranked

3 citations

Sophia Lewis, Mark C. Valentine, M. Palisoul, Premal H. Thaker, Andrea R. Hagemann +6 more

Ridiculously good writing: How to write like a pro and publish like a boss

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101024

N/A

0DataRank · unranked

3 citations

Laura J. Havrilesky, Rebecca A. Previs, Jose Alejandro Rauh‐Hain, J. Michael Straughn, Jamie N. Bakkum‐Gamez +3 more

Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101075

N/A

0DataRank · unranked

1 citations

Angela L. Mazul, Christine Marx, Mary M. Mullen, Molly M. Greenwade, L. Stewart Massad +9 more

DDR2-regulated arginase activity in ovarian cancer-associated fibroblasts promotes collagen production and tumor progression

Oncogene(2023)10.1038/s41388-023-02884-3

N/A

0DataRank · unranked

47 citations

Zainab Ibitoye, Peinan Zhao, Leah P. Shriver, Gary J. Patti, Gregory D. Longmore +2 more

Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-23-0347

N/A

0DataRank · unranked

22 citations

Molly M. Greenwade, Elizabeth Stock, Elena Lomonosova, Kevin Cho, Whitney R. Grither +17 more

Reproductive Scientist Development Program: Bridging the Gap to the Physician Scientist Career

Reproductive Sciences(2023)10.1007/s43032-023-01234-8

N/A

0DataRank · unranked

2 citations

Emily R. Boniface, Amanda Heflin, Aleksandar Stanic-Kostic, Katherine C. Fuh, Danny J. Schust +1 more

Safety Evaluations of Rapamycin Perfluorocarbon Nanoparticles in Ovarian Tumor Bearing Mice

Journal of Pharmacology and Experimental Therapeutics(2023)10.1124/jpet.122.507130

N/A

0DataRank · unranked

0 citations

Qingyu Zhou, Antonina Akk, John C. S. Harding, Luke E. Springer, Joseph P. Gaut +8 more

ROR2/Wnt5a Signaling Regulates Directional Cell Migration and Early Tumor Cell Invasion in Ovarian Cancer

Molecular Cancer Research(2024)10.1158/1541-7786.mcr-23-0616

N/A

0DataRank · unranked

11 citations

Breanna Baker, Vasilios A. Morikis, Ma. Xenia G. Ilagan, Katherine C. Fuh, Gregory D. Longmore +1 more

Safety Evaluations of Rapamycin Perfluorocarbon Nanoparticles in Ovarian Tumor-Bearing Mice

Nanomaterials(2024)10.3390/nano14211752

N/A

0DataRank · unranked

0 citations

John C. S. Harding, Ping Fan, Ivan Spasojević, Attila Kovács, Antonina Akk +9 more

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination–proficient ovarian cancer

Journal of Clinical Investigation(2025)10.1172/jci189511

N/A

0DataRank · unranked

7 citations

Amanda Compadre, Rebecca Drexler, Megan Loeb, Kevin Rodriguez, Joshua Brill +22 more

APOBEC3A drives ovarian cancer metastasis by altering epithelial-mesenchymal transition

JCI Insight(2025)10.1172/jci.insight.186409

N/A

0DataRank · unranked

5 citations

Thi Tran, Brooke R. Harris, Dylan Fingerman, Rachel A. DeWeerd, Lojain H Elkhidir +8 more

Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity

Nature Communications(2025)10.1038/s41467-025-60745-x

N/A

0DataRank · unranked

4 citations

Meng Zhang, Tatyanah Farsh, Haolong Li, Audrey Kishishita, Abhilash Barpanda +22 more

Effect on response to neoadjuvant chemotherapy in high-grade serous ovarian cancer by inhibiting the GAS6/AXL pathway and inducing homologous recombination deficiency.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6080

N/A

0DataRank · unranked

0 citations

Elena Lomonosova, Michael Toboni, Hollie Noia, Danny Wilke, Alyssa Oplt +9 more

Aging increases ovarian cancer growth, metastasis, and immunosuppression that can be alleviated by inhibiting hedgehog signaling

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.64898/2025.12.23.695206

N/A

0DataRank · unranked

0 citations

Mohamed Elbahoty, Resha Rajkarnikar, Khushi Sureja, Mehri Monavarian, Liz Macias Quintero +6 more

A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.02.027

N/A

0DataRank · unranked

15 citations

Tyler McKinnish, Mark A. Fiala, Abigail Zamorano, Lindsay M. Kuroki, Katherine C. Fuh +7 more

Katherine C. Fuh

Indexed papers

Top data-sharing exemplar

Papers